NSM in Dallas, TX







If you take an honest look at ppr's you will see that the Reliance is by far the safest and most reliable shock lead ever.

Two words for you - ACTIVE and PASSIVE, as in surveillance. Reliance "performance" is based on passive surveillance - in other words, waiting for the lead to fail, be pulled out, and returned, or the physician to call with a complaint. Kinda like Minneapolis bridge inspectors - they should know that you need to get out there and actively look for problems, like St. Jude does with the SCORE registry - hell, even Medtronic does that in their PPR.
 






Left BSX a year ago. I miss some friends, most patients, and my MDs as I work off a non-compete. I do not miss the failure to deliver the following as promised at numerous sales meetings:

* Non OEM ext/ret brady lead
* Acuity Spiral bipolar (shelved for quadrapolar which is years away)
* Brady remote follow-up (probably the biggest issue)
* Completely coated Gore leads
* A FUCKING PSA
* Ingenio (told my customer it would be here Q1 2010 if all goes well at FDA)
* Multisense - finally out but most engineers have bugged out so it will be years before it becomes a usable device to heart failure MDs
* Software fix for respiratory rate sensor
* SRD2 - Remon Medical - shelved

When your customers tell you its time to go and thank you for riding out the recall storm with them, you leave. Protect your family. Stop selling incompetence. Move on.

The chatter on this board is entertaining but the truth is BSX is in a death spiral. If you're not on an EA, get out or volunteer for the RIF.

God Speed!
 


















Here here! Anyone who posts on this trashy board is inferior. You should all be role playing very realistic talk tracks on how MV is BLENDED with magic and unicorn hair. We don't need new products, We are CRV!!!
 


















You BSX people don't understand. We, MDT, TOLD our patients that they had a lead that really sucked, that it is the 2nd worst tachy lead in history (#1 is our own Transvene, so we own #1 and #2). We couldn't fix Fidelis because we barely understand how a lead flexes inside the ventricle so we pulled it. Well, maybe we fudged the failure rate a little bit, we initially announced that it was 1.4% or so and maybe we already knew that it would go above 5%

Guidant didn't tell patients that they had a .0003% chance that their defib would fail and they they had already fixed the problem for new implants. In other industries that is called continuous improvement.


See, don't you understand ethics?